Popliteal Artery Occlusive Disease 

  • Author: Cynthia K Shortell, MD; Chief Editor: Vincent Lopez Rowe, MD   more...
 
Updated: Aug 12, 2011
 

Background

Popliteal artery occlusive disease is a common occurrence, especially in elderly patients, smokers, and those with diabetes mellitus and other cardiovascular diseases. Each year, more than 100,000 peripheral arterial reconstructive operations and 50,000 lower limb amputations for lower extremity limb ischemia are performed in the United States. Many of these are related to popliteal artery disease.

Next

Problem

Popliteal artery occlusion and the disease processes leading up to it cause morbidity and mortality by decreasing or completely blocking blood supply through the popliteal artery and into the lower leg and foot. As a result of tissue ischemia, these patients have a significant reduction in ambulatory activity, daily functional capacity, and quality of life. Lower extremity ischemia can manifest as claudication, rest pain, or tissue loss (gangrene) and can lead to limb loss.

Once a portion of a lower extremity becomes gangrenous, the patient is at risk for limb loss and death. Diagnosing popliteal artery occlusive disease is very important because of the risk of limb-threatening ischemia, thrombosis, or distal embolization. In addition, patients with peripheral artery disease (PAD), in general, have markedly increased prevalence of coronary artery disease (CAD) and cerebrovascular disease and mortality. Recognition of this relationship allows for proper management of medical comorbidities and risk factor reduction.

In addition to atherosclerosis, popliteal artery occlusive disease can be caused by emboli, popliteal entrapment syndrome, cystic adventitial disease, and trauma.

Previous
Next

Epidemiology

Frequency

Atherosclerosis is by far the most common cause of popliteal artery occlusive disease. More than a million patients experience symptomatic disability related to atherosclerotic PAD in the United States each year. Moreover, atherosclerotic PAD is increasing in prevalence as a result of increased life expectancy.

Popliteal artery aneurysms (PAA) are the most common peripheral aneurysms. They occur in 0.01% of all hospitalized patients. From 50-70% of aneurysms are bilateral.

Fifteen percent of lower extremity emboli affect the popliteal artery. Atrial fibrillation is currently associated with two thirds to three quarters of all peripheral arterial embolization. Myocardial infarction is the next most important cause of peripheral emboli.

Popliteal entrapment syndrome is a rare cause of popliteal artery occlusive disease, with an estimated prevalence of 0.16%. This syndrome occurs most commonly in young (60% < 30 years old), healthy men (15:1 male predilection) who present with symptoms of calf claudication.

Cystic adventitial disease is an extremely rare cause of popliteal artery occlusion, accounting for only 254 reported cases since the first description by Ejrup and Hiertonn in 1954.

Previous
Next

Pathophysiology

During exercise, muscles require 2-10 times more oxygenated blood than when at rest. Mild nonocclusive arterial obstruction minimally affects resting blood flow but severely curtails the body's response to exercise. The first symptom of a decrease in the body's ability to deliver blood is ischemic pain during exercise. As the stenosis worsens, pain at rest and tissue loss follow.

As the stenosis progresses and proceeds to occlusion, collateral vessels, via the descending genicular artery, propagate and flourish, providing the distal leg with much needed arterial blood. However, collateral circulation does not provide the amount of blood needed in the exercising leg, and it does not guarantee leg viability. The extent to which different tissues in the lower extremity can tolerate ischemia depends on their metabolic rates. In general, muscles and nerves are the least resistant to ischemia, with an estimated ischemic tolerance of 6 hours. In the absence of sufficient collateral blood flow in the extremity with an occluded popliteal artery, limb viability is jeopardized. If the occluded popliteal artery is not treated in case of tissue loss, significant morbidity and mortality can result.

Atherosclerosis

Atherosclerotic disease isolated to the popliteal vessels is not common; however, popliteal artery occlusive disease as a result of systemic atherosclerosis associated with other lesions is extremely common. Popliteal artery occlusion is usually the end stage of a long-standing disease process of atheromatous plaque formation. Once formed, the atherosclerotic core is a highly thrombogenic surface that promotes platelet aggregation, which results in disturbances of blood flow. As the atherosclerotic lesion enlarges, normal laminar flow in the artery is disrupted, causing eddy currents and thrombus formation. Endothelial damage activates the repair process that results in neointimal hyperplasia, which results in additional attraction of platelets. Additionally, ulcerated plaques promote local thrombus formation, and the result is a primary popliteal thrombus that occludes flow.

Popliteal artery aneurysm

The exact cause of PAA is not known. Recent molecular studies suggest that PAAs are caused by a combination of a genetic defect and inflammation. Infiltration of inflammatory cells has been documented by observing that the PAA wall is associated with increased apoptosis and degeneration of extracellular matrix. Historically, the common causes of PAA were mycotic, syphilitic, or traumatic in nature. As the population ages, arteriosclerosis seems to be the dominant associated factor. Turbulent flow distal to arteriosclerotic lesions is believed to result in distal dilation of the vessel at the adductor hiatus. Decreased wall strength, turbulent flow, and constant kinking and motion from normal movement of the knee joint are believed to result in aneurysm formation.

Emboli

Fifteen percent of emboli emanating from proximal sources result in popliteal disease. Common sources include mural thrombi in the heart, diseased heart valves, abdominal aortic aneurysms (AAA), or iliac aneurysms.

Popliteal entrapment syndrome

Popliteal entrapment syndrome is a developmental anomaly characterized by an abnormal anatomic relationship of the popliteal artery to the gastrocnemius muscle. This anomalous anatomic relationship causes popliteal artery compression and occlusion. In rare cases, the popliteal artery is compressed by a fibrous band or by the popliteus muscle. In 1985, Mosimann postulated that increased use of the knee joint causes intimal fibrosis of the vessel lumen, thereby decreasing flow and causing claudication and eventual occlusion.[1]

Cystic adventitial disease

The mechanism of cystic adventitial disease was first thought to be a primary dysplasia of the blood vessel wall. In a 1984 report, Leu and associates suggest that the cysts associated with this disease originate from ectopic tissue of the joint capsule or bursa.[2] Following some type of trauma to the popliteal area, collagenous and muscular fibers in the joint and the myocytes around it undergo focal necrosis. Multiple loculated cysts result, the lumen of which are filled with mucinous material containing amino acids without carbohydrates, cholesterol, or calcium. The cysts in the adventitia compress the popliteal artery, either causing thrombus or directly impinging and occluding arterial blood flow.

Trauma

Injuries to the popliteal arteries may cause intimal damage and subsequent thrombus formation. Injuries affecting the popliteal artery are most commonly caused by anterior and posterior knee dislocation, as well as bony fractures. Motor vehicle accidents and penetrating trauma are the most common causes of popliteal artery injury. Due to its anatomic proximity to the distal femur and knee joint, trauma of the popliteal artery can also be related to iatrogenic injuries during knee surgery or intervention.

Previous
Next

Presentation

With the exceptions of acute thrombosis, emboli and trauma, the course of disease culminating in popliteal artery occlusion is insidious. Most commonly, patients present with intermittent claudication. Patients experience cramping pain distal to the level of obstruction. Symptoms are highly reproducible and disappear with rest. Other conditions involving the lower extremity should be differentiated from intermittent claudication. These include pseudoclaudication, lumbar disc disease, and spinal stenosis. In most cases, the differential diagnosis between true claudication and pseudoclaudication can be made based on careful history taking. The mortality rate associated with patients who present with claudication is 50% at 5 years.

Rest pain represents the next clinical step in the progression of PAD and is a pathognomonic sign of critical limb ischemia. Rest pain characteristically presents as a burning in the toes, forefoot, and instep. It is aggravated by elevation and frequently awakens the patient at night. The pain is relieved by dependency (dangling the feet or a brief walk). When taking the patient’s history, distinguishing true rest pain from other causes (eg, arthritis and neuropathy) is important.

Mortality rates for patients presenting with rest pain reaches 75% at 5 years and 85 % at 10 years and are inversely proportional to the ankle brachial index (ABI) at the time of presentation. Patients with the most severe manifestations of PAD present with ischemic ulcerations and gangrene. Lesions are typically located at the tips of toes and over pressure points. Patients with rest pain and gangrene should undergo revascularization for limb salvage and preservation of function if they are ambulatory and do not have prohibitive comorbidities.

Atherosclerosis

These patients are older (sixth and seventh decades of life) and may be asymptomatic or have claudication, rest pain, or tissue ischemia or loss below the knee. Chronic decreased blood supply also manifests as loss of hair on the affected limb, thickened toenails, dependent rubor, and pallor upon elevation.

Popliteal artery aneurysm

At the time of presentation, approximately two thirds of patients are symptomatic. The most common presenting symptoms are lower extremity ischemia and compression of adjacent anatomic structures, notably nerves (causing paresthesias) and veins (leading to deep vein thrombosis and edema). Patients typically present in their sixth or seventh decade of life, with a pulsatile mass in the subsartorial or popliteal area, as observed upon physical examination.

The major complications of PAA result from thrombosis and embolism. Thrombosis occurs in as many as 55% of patients, and 6-25% of patients have evidence of distal emboli. Many patients with acute PAA thrombosis present emergently with limb-threatening ischemia. Rarely, these aneurysms can rupture, causing a threat to leg viability. Limb-threatening ischemia associated with PAA rupture results in a 50-70% amputation rate. Rupture of PAA is uncommon, occurring in approximately 2-7% of cases. This occurs much less frequently than thrombosis of the aneurysm. By contrast, AAA is more likely to rupture than thrombose.

Emphasizing that 33-43% PAA are associated with a coexisting AAA is important. A high index of suspicion in these patients should result in a careful evaluation of the aorta, iliac, femoral, and contralateral popliteal arteries. Patients with bilateral PAA extrapopliteal aneurysm are even more common, with a reported incidence as high as 78%.

Popliteal entrapment syndrome

These patients are young, otherwise healthy, athletic males who present with symptoms of calf claudication. In rare cases, paresthesia, rest pain, or ulcer might be present. The symptoms most commonly described include aching and cramping in the calf or foot and coldness, blanching, and numbness in the foot associated with walking and relived by rest. ABI at rest is normal. Findings from Doppler examinations at rest are normal. Abnormal findings after Doppler examination with dorsiflexion of the foot are diagnostic of popliteal entrapment syndrome.

Cystic adventitial disease

Patients are usually healthy, nonsmoking, middle-aged men with a sudden onset and rapid progression of intermittent claudication. The important physical examination sign is a loss of foot pulses with knee flexion (Ishizawa sign). This demonstrates that cystic disease has resulted in stenosis of the popliteal artery with preservation of patency. With progressive narrowing of the arterial lumen, blood flow may possibly occur only during the peak of a systole. The altered blood flow can be auscultated as a bruit in the popliteal fossa. Symptoms are predominately unilateral. In time, enlargement of the cyst can cause total occlusion of the popliteal artery. Given the slow progressive nature of the occlusion caused by adventitial cystic disease and healthy proximal and distal arteries, acute limb threat is unlikely to occur.

Previous
Next

Indications

Regardless of the reason for popliteal artery occlusion, intervention is indicated in patients with severe claudication that alters lifestyle and does not respond to medical treatment and in patients with critical limb ischemia.

Patients with infection or gangrene in deeper tissues require amputation. Amputation is also indicated for those patients who are unable to ambulate because of reasons other than popliteal artery occlusive disease. However, special consideration should be given to those patients in whom the effect of amputation would have deleterious effects on the ability to transfer to or balance in a wheelchair.

Table 1. Indications for Diagnostic and Therapeutic Interventions[3] (Open Table in a new window)

StagePresentationDiagnostic and Therapeutic Indications
0No signs or symptomsNever justified
IIntermittent claudication (1 block) without physical changesUsually unjustified
IISevere claudication (less than half blocked), dependent rubor, decreased temperatureSometimes justified, not always necessary, may remain stable
IIIRest pain, atrophy, dependent cyanosis, decreased temperatureUsually indicated but patient may do well for long periods of time without revascularization
IVNonhealing ischemic ulcer or gangreneIndicated
Previous
Next

Relevant Anatomy

The popliteal artery is characterized by distinct embryologic and anatomic features when compared with the femoral vessels. Embryologically, unlike the superficial femoral artery, the popliteal artery originates from the sciatic system.[4]

The popliteal artery sits on the posterior aspect of the leg, in the popliteal fossa. The superficial femoral artery becomes the popliteal artery as it passes through the adductor hiatus, and it proceeds until it bifurcates into the anterior tibial artery and the tibioperoneal trunk. The tibioperoneal trunk divides into the posterior tibial and peroneal arteries. The popliteal artery is located between the two heads of gastrocnemius muscle. It lies posterior to the distal femur and anterior to the popliteal vein. The anatomic proximity of the popliteal artery to the distal femur and gastrocnemius muscle makes this artery susceptible to injury during femoral fracture or knee dislocation and entrapment syndrome, respectively.

Compared with the superficial femoral artery, the popliteal artery is not located within the muscular compartment and is subjected to significant biomechanical torsional forces related to the repetitive knee flexion and extension.[5, 6, 7] This anatomical region is characterized by a high biomechanical stress, which consequently negatively affects patency rates associated with the popliteal artery bypass procedures and imposes technical limitations for endovascular stenting, since biomechanical stress may lead to stent fractures.

At the level of the knee, the popliteal artery gives off genicular and sural branches. Above the knee joint it gives off the superior lateral and the superior medial genicular arteries. Below the knee, it gives off the inferior lateral and the inferior medial genicular arteries. These branches provide a rich network between the superficial femoral artery, the profunda femoris, and the tibial arteries. This collateral circulation is very important in the presence of chronic occlusive disease of the popliteal artery.

Previous
Next

Contraindications

The vast majority of patients with atherosclerotic disease that is severe enough to cause popliteal artery occlusion have atherosclerotic disease elsewhere (including the coronary circulation). These patients require a workup to determine their operative morbidity and mortality risks. Those with CAD (or any other disease) significant enough to substantially increase morbidity and mortality should be managed by either conservative medical therapies or limb amputation.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Cynthia K Shortell, MD  Professor of Surgery, Associate Professor of Radiology, Chief of Vascular Surgery, Program Director, Vascular Surgery Residency Program, Duke University Medical Center

Disclosure: Medical Simulation Corporation Grant/research funds Principal Investigator

Coauthor(s)

Jovan N Markovic, MD  General Surgery Resident, Department of Surgery, Duke University Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Richard M Stillman†, MD, FACS  Honorary Medical Staff, Northwest Medical Center; Former Chief of Staff and Medical Director, Wound Healing Center, Department of Surgery, Northwest Medical Center

Richard M Stillman†, MD, FACS is a member of the following medical societies: American College of Angiology, American College of Surgeons, Association for Academic Surgery, and Society of University Surgeons

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Vincent Lopez Rowe, MD  Associate Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center

Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, Pacific Coast Surgical Association, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Western Vascular Surgical Society

Disclosure: Nothing to disclose.

Paolo Zamboni, MD  Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy

Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences

Disclosure: Nothing to disclose.

Chief Editor

Vincent Lopez Rowe, MD  Associate Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center

Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, Pacific Coast Surgical Association, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Western Vascular Surgical Society

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors, Deron J Tessier, MD, and Russell A Williams, MBBS, to the development and writing of this article.

References
  1. Mosimann R, Walder J, Van Melle G. Stenotic intimal thickening of the external iliac artery: illness of the competitive cyclist?. Vasc Surg. 1985;19:258-63.

  2. Leu HJ, Largiader J, Odermatt B. Pathogenesis of the so-called cystic adventitial degeneration of peripheral blood vessels. Virchows Arch A Pathol Anat Histopathol. 1984;404(3):289-300. [Medline].

  3. Veith FJ, Ascer E, Gupta SK. Femoral-Popliteal-Tibial Occlusive Disease. In: Vascular Surgery: A Comprehensive Review. 2nd ed. New York, NY: Grune & Stratton; 1986:513-58.

  4. Sadler TW. Langman's Medical Embryolog. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2006.

  5. Valentine RJ, Wind GG. Anatomic Exposures in Vascular Surgery. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003.

  6. Kröger K, Santosa F, Goyen M. Biomechanical incompatibility of popliteal stent placement. J Endovasc Ther. Dec 2004;11(6):686-94. [Medline].

  7. Hoffmann U, Vetter J, Rainoni L, Leu AJ, Bollinger A. Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg. Aug 1997;26(2):281-7. [Medline].

  8. Vroegindeweij D, Tielbeek AV, Buth J, Schol FP, Hop WC, Landman GH. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. J Vasc Surg. Feb 1995;21(2):255-68; discussion 268-9. [Medline].

  9. Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. Oct 17 2006;48(8):1573-8. [Medline].

  10. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther. Oct 2006;13(5):592-602. [Medline].

  11. Otsuka Y, Kasahara Y, Kawamura A. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque. J Invasive Cardiol. Dec 2007;19(12):E359-62. [Medline].

  12. Spaargaren GJ, Lee MJ, Reekers JA, van Overhagen H, Schultze Kool LJ, Hoogeveen YL. Evaluation of a new balloon catheter for difficult calcified lesions in infrainguinal arterial disease: outcome of a multicenter registry. Cardiovasc Intervent Radiol. Jan 2009;32(1):132-5. [Medline]. [Full Text].

  13. Minko P, Katoh M, Jaeger S, Buecker A. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol. Jul 2011;22(7):995-1000. [Medline].

  14. Abraham P, Chevalier JM, Leftheriotis G, et al. Lower extremity arterial disease in sports. Am J Sports Med. Jul-Aug 1997;25(4):581-4. [Medline].

  15. Aronow WS. Management of peripheral arterial disease of the lower extremities. Compr Ther. Winter 2007;33(4):247-56. [Medline].

  16. Barral X, Salari GR, Toursarkissian B, et al. Bypass to the perigeniculate collateral vessels. A useful technique for limb salvage: preliminary report on 22 patients. J Vasc Surg. May 1998;27(5):928-35. [Medline].

  17. Chew DK, Owens CD, Belkin M, et al. Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein. J Vasc Surg. Jun 2002;35(6):1085-92. [Medline].

  18. Davidovic LB, Lotina SI, Kostic DM, et al. Popliteal artery aneurysms. World J Surg. Aug 1998;22(8):812-7. [Medline].

  19. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. Nov 2000;109(7):523-30. [Medline].

  20. Dawson I, Sie RB, van Bockel JH. Atherosclerotic popliteal aneurysm. Br J Surg. Mar 1997;84(3):293-9. [Medline].

  21. Farber A, Major K, Wagner WH, et al. Cryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 grafts. J Vasc Surg. Jul 2003;38(1):15-21. [Medline].

  22. Fleischmann D, Hallett RL, Rubin GD. CT angiography of peripheral arterial disease. J Vasc Interv Radiol. Jan 2006;17(1):3-26. [Medline].

  23. Galland RB. Popliteal aneurysms: controversies in their management. Am J Surg. 2005;190:314-8. [Medline].

  24. Gulba DC, Bode C, Runge MS, et al. Thrombolytic agents--an overview. Ann Hematol. 1996;73 Suppl 1:S9-27. [Medline].

  25. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. May 24 2001;344(21):1608-21. [Medline].

  26. Jacob T, Schutzer R, Hingorani A, et al. Differential expression of YAMA/CPP-32 by T lymphocytes in popliteal artery aneurysm. J Surg Res. Jun 15 2003;112(2):111-6. [Medline].

  27. Lumsden AB, Rice TW. Medical management of peripheral arterial disease: a therapeutic algorithm. J Endovasc Ther. Feb 2006;13 Suppl 2:II19-29. [Medline].

  28. Maurer DH, Collins WE, Hanke JH, et al. Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation. Hum Immunol. Nov 1985;14(3):245-58. [Medline].

  29. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. Jul 28 2004;292(4):453-61. [Medline].

  30. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol. Mar 2004;7(1):2-5. [Medline].

  31. Muradin GS, Bosch JL, Stijnen T, et al. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. Oct 2001;221(1):137-45. [Medline].

  32. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol. Jun 2007;26(2):81-157. [Medline].

  33. [Best Evidence] Ouwendijk R, de Vries M, Pattynama PM, et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology. Sep 2005;236(3):1094-103. [Medline].

  34. Owens CD, Ho KJ, Conte MS. Lower extremity vein graft failure: a translational approach. Vasc Med. Feb 2008;13(1):63-74. [Medline].

  35. Porter JM, Taylor LM, Masser PH. Technique of Reversed Vein Bypass for Lower-Extremity Ischemia. In: Nyhus LM, Baker RJ, eds. Mastery of Surgery. 3rd ed. Boston, Mass: Little, Brown and Company; 1992:2083-90.

  36. Pulli R, Dorigo W, Troisi N, et al. Surgical management of popliteal artery aneurysms: which factors affect outcomes?. J Vasc Surg. Mar 2006;43(3):481-7. [Medline].

  37. Ramaswami G, Marin ML. Stent grafts in occlusive arterial disease. Surg Clin North Am. Jun 1999;79(3):597-609. [Medline].

  38. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation. Oct 30 2007;116(18):2072-85. [Medline].

  39. Rosenthal D, Martin JD, Kirby LB, et al. Minimally invasive in situ bypass. Surg Clin North Am. Jun 1999;79(3):645-52, x. [Medline].

  40. Rowlands TE, Donnelly R. Medical therapy for intermittent claudication. Eur J Vasc Endovasc Surg. Sep 2007;34(3):314-21. [Medline].

  41. Schanzer A, Hevelone N, Owens CD, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. Dec 2007;46(6):1180-90; discussion 1190. [Medline].

  42. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. Jan 18 2005;45(2):312-5. [Medline].

  43. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. Aug 10 2004;110(6):738-43. [Medline].

  44. Shortell CK, DeWeese JA, Ouriel K, et al. Popliteal artery aneurysms: a 25-year surgical experience. J Vasc Surg. Dec 1991;14(6):771-6; discussion 776-9. [Medline].

  45. Taylor LM, Porter JM, Masser PH. Femoropopliteal and infrapopliteal occlusive disease. In: Greenfield LJ, ed. Surgery: Scientific Principles and Practices. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1997:1810-23.

  46. Taylor SM, Kalbaugh CA, Healy MG, et al. Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? A single center experience of 1,000 consecutively treated limbs. J Am Coll Surg. May 2008;206(5):1053-62; discussion 1062-4. [Medline].

  47. Tsolakis IA, Walvatne CS, Caldwell MD. Cystic adventitial disease of the popliteal artery: diagnosis and treatment. Eur J Vasc Endovasc Surg. Mar 1998;15(3):188-94. [Medline].

  48. Turnipseed WD. Diagnosis and management of chronic compartment syndrome. Surgery. Oct 2002;132(4):613-7; discussion 617-9. [Medline].

  49. Verhelst R, Bruneau M, Nicolas AL, et al. Popliteal-to-distal bypass grafts for limb salvage. Ann Vasc Surg. Sep 1997;11(5):505-9. [Medline].

  50. Walker SR, Yusuf SW, Hopkinson BR. A 10-year follow-up of patients presenting with ischaemic rest pain of the lower limbs. Eur J Vasc Endovasc Surg. Jun 1998;15(6):478-82. [Medline].

  51. White C. Clinical practice. Intermittent claudication. N Engl J Med. Mar 22 2007;356(12):1241-50. [Medline].

Previous
Next
 
Table 1. Indications for Diagnostic and Therapeutic Interventions[3]
StagePresentationDiagnostic and Therapeutic Indications
0No signs or symptomsNever justified
IIntermittent claudication (1 block) without physical changesUsually unjustified
IISevere claudication (less than half blocked), dependent rubor, decreased temperatureSometimes justified, not always necessary, may remain stable
IIIRest pain, atrophy, dependent cyanosis, decreased temperatureUsually indicated but patient may do well for long periods of time without revascularization
IVNonhealing ischemic ulcer or gangreneIndicated
Table 2. Clinical Category and ABI
Clinical Category ABI
Normal>0.97 (usually 1.10)
Claudication0.40-0.80
Rest pain0.20-0.40
Tissue loss0.10-0.40
Acute ischemia< 0.10
Table 3. Rutherfod and Fontaine Classifications
RutherfordFontaine
GradeCategoryClinicalStageClinical
00AsymptomaticIAsymptomatic
I1Mild claudicationIIaMild claudication
I2Moderate claudicationIIbModerate to severe claudication
I3Severe claudicationIschemic rest pain
II4Ischemic rest painIIIIschemic rest pain
III5Minor tissue lossIVUlceration or gangrene
III6Major tissue loss
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.